Dr. Reddy's Laboratories
194 hedge funds and large institutions have $1.31B invested in Dr. Reddy's Laboratories in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 82 increasing their positions, 55 reducing their positions, and 21 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
49% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 55
22% more capital invested
Capital invested by funds: $1.07B → $1.31B (+$236M)
19% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 21
5.82% more ownership
Funds ownership: 56.41% → 62.23% (+5.8%)
2% more funds holding
Funds holding: 190 → 194 (+4)
87% less call options, than puts
Call options by funds: $56K | Put options by funds: $435K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$23.3M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$12.8M |
| 3 |
Goldman Sachs
New York
|
+$12.6M |
| 4 |
Millennium Management
New York
|
+$12.1M |
| 5 |
Jane Street
New York
|
+$12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$20M |
| 2 |
SO
STRS Ohio
Columbus,
Ohio
|
-$10.8M |
| 3 |
D.E. Shaw & Co
New York
|
-$6.44M |
| 4 |
MGI
MayTech Global Investments
New York
|
-$5.18M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.78M |
RDY Hedge Fund Activity: Q2 2023 in Review
194 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2023, worth a combined $1.31B — up 22% from $1.07B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new RDY positions and 21 closed out — a net gain of 4 holders — while 82 added to existing stakes and 55 trimmed.
The largest buyer was Robeco Institutional Asset Management, adding an estimated $23.3M. The largest seller was BlackRock, cutting an estimated $20M.
- 194 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2023, up from 190 in Q1 2023.
- Funds reported $1.31B of Dr. Reddy's Laboratories stock for Q2 2023, up 22% quarter-over-quarter.
- 25 funds opened new Dr. Reddy's Laboratories positions in Q2 2023 and 21 closed out, a net change of +4 holders.
- The largest Dr. Reddy's Laboratories buyer in Q2 2023 was Robeco Institutional Asset Management, an estimated $23.3M added.
- The largest Dr. Reddy's Laboratories seller in Q2 2023 was BlackRock, an estimated $20M sold.
Based on aggregated 13F filings for Q2 2023.